Member Info for TrickyEFC

aat****z. the early data is very strong

phase 2 results demonstrated a 50% reduction in heavy drinking days in the 6 months post treatment versus the placebo. the phase 2 results also demonstrated an on average 86% abstinence rate in the 6 months post treatment versus 2% abstinence pre-trial

daffy market cap here is and has been a massive **** take for about 5 months now.

how this ain't near 15 mill value with the take over of awakn, the board that has been put together and most importantly the progress that they have made.

it's ******* crazy

From my previous tip.

💪

For any not onboard

Adrian Dawkes, Managing Director of PharmaVentures, commented: "Based on market comparables and recent transactions in the substance use disorder space, our analysis highlights the significant commercial potential of these two clinical-stage programmes with potential value based on comparable assets of more than £200 million as well as future material royalties on net sales. Combined, AWKN-001 and AWKN-002 represent a significant commercial opportunity with potential for significant licensing deals with substantial future royalty streams."

Anthony Tennyson, CEO of Solvonis, added: "We are pleased to be working with PharmaVentures to unlock the full value of these transformative mental health treatments. Completing the market analysis phase marks an important milestone, and we're excited to share these encouraging results. Our mission remains clear: to bring life-changing therapies to patients while creating lasting value for our

Adrian Dawkes, Managing Director of PharmaVentures, commented: "Based on market comparables and recent transactions in the substance use disorder space, our analysis highlights the significant commercial potential of these two clinical-stage programmes with potential value based on comparable assets of more than £200 million as well as future material royalties on net sales. Combined, AWKN-001 and AWKN-002 represent a significant commercial opportunity with potential for significant licensing deals with substantial future royalty streams."

Anthony Tennyson, CEO of Solvonis, added: "We are pleased to be working with PharmaVentures to unlock the full value of these transformative mental health treatments. Completing the market analysis phase marks an important milestone, and we're excited to share these encouraging results. Our mission remains clear: to bring life-changing therapies to patients while creating lasting value for our

Just glanced at the RNs.

Wowzer.

Seems massive

Https://www.globenewswire.com/news-release/2025/04/02/3054192/0/en/Infinite-Reality-Now-Available-on-Google-Cloud-Marketplace-Scaling-Access-to-Immersive-3D-Experiences-for-Businesses-of-All-Sizes.html

Player no it's not.

Id say that the rise up until yesterday is more caus for concern than a tariff.

It's risen sooo much on nothing of solid value.

Tariffs won't hit us one bit I believe onwards today

01-Apr-25 08:22:03 1.00 3,750,000 Unknown* 37.50k

Yesterday morn.

Little north movement yesterday, followed a higher % gain today.

Good buying pressure on display today.

i think everyone will concur that a seller can be the only reason this ain't closer to the 2p mark than the 1p

Do we fly tomorrow Bobby????

That's an increase of over 6.5mill

Was 3.5 other day

Could sell over 10 million for the same price I could buy 500k

💪💪

Selling qssholes

If this looks like what it looks like.

Another holdings RNs coming

Been plenty of something going on round this current share price

1.1p gonna go

Posts till bids at 1.2.

Volume picked up

Nice

??

Let's get the bid over 1.1p and see what happens